| Dr Tanya D Reid, OD | |
|
1450 S Grand Ave, Pullman, WA 99163-4900 | |
| (509) 332-0820 | |
| (509) 332-0233 |
| Full Name | Dr Tanya D Reid |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 1450 S Grand Ave, Pullman, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528010121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | WA3665 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shoptikal Llc | 1456684471 | 162 |
| Shoptikal Llc | 1456684471 | 162 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.
As part of National Minority Cancer Awareness Week during April 15 to 21, The University of Texas MD Anderson Cancer Center has developed a series of food plate worksheets that focus on nutrition and cancer prevention for African American, Hispanic and Vietnamese audiences.
PDI, Inc. subsidiary, Interpace Diagnostics, announced today new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX Thyroid Oncogene Panel, a DNA and RNA mutational analysis, to improve thyroid cancer diagnosis.
Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential.
› Verified 2 days ago
| Provider Name | Moscow Family Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467885558 PECOS PAC ID: 8921235664 Enrollment ID: O20131230000311 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.
As part of National Minority Cancer Awareness Week during April 15 to 21, The University of Texas MD Anderson Cancer Center has developed a series of food plate worksheets that focus on nutrition and cancer prevention for African American, Hispanic and Vietnamese audiences.
PDI, Inc. subsidiary, Interpace Diagnostics, announced today new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX Thyroid Oncogene Panel, a DNA and RNA mutational analysis, to improve thyroid cancer diagnosis.
Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential.
› Verified 2 days ago
| Provider Name | Shoptikal Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063078442 PECOS PAC ID: 1456684471 Enrollment ID: O20190610000806 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.
As part of National Minority Cancer Awareness Week during April 15 to 21, The University of Texas MD Anderson Cancer Center has developed a series of food plate worksheets that focus on nutrition and cancer prevention for African American, Hispanic and Vietnamese audiences.
PDI, Inc. subsidiary, Interpace Diagnostics, announced today new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX Thyroid Oncogene Panel, a DNA and RNA mutational analysis, to improve thyroid cancer diagnosis.
Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tanya D Reid, OD 1450 S Grand Ave, Pullman, WA 99163-4900 Ph: (509) 332-0820 | Dr Tanya D Reid, OD 1450 S Grand Ave, Pullman, WA 99163-4900 Ph: (509) 332-0820 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
In an effort to develop and deliver treatments for children with tuberculosis—answering a critical need in public health today—TB Alliance, a not-for-profit organization with the mission to develop better, faster-acting, and affordable drugs for TB, has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments.
As part of National Minority Cancer Awareness Week during April 15 to 21, The University of Texas MD Anderson Cancer Center has developed a series of food plate worksheets that focus on nutrition and cancer prevention for African American, Hispanic and Vietnamese audiences.
PDI, Inc. subsidiary, Interpace Diagnostics, announced today new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX Thyroid Oncogene Panel, a DNA and RNA mutational analysis, to improve thyroid cancer diagnosis.
Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential.
› Verified 2 days ago
Eye And Wellness, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1690 Se Harvest Dr, Pullman, WA 99163 Phone: 509-334-2990 | |
Family Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 560 Se Bishop Blvd, Pullman, WA 99163 Phone: 509-334-3300 Fax: 509-334-7591 | |
Dr. James P Devleming, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 238 E Main St, Pullman, WA 99163 Phone: 509-334-1131 Fax: 509-332-4062 | |
Dr. Rachna Narula, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1125 Se Washington St, Pullman, WA 99164 Phone: 509-335-0360 | |
Dr. Suzanne Denise Scott, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1045 N Grand Ave, Suite E, Pullman, WA 99163 Phone: 509-334-3610 Fax: 509-334-1462 | |
Dr. Darin Lee Paulson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1045 N Grand Ave, Suite E, Pullman, WA 99163 Phone: 509-334-3610 Fax: 509-334-1462 | |
Rolling Hills Eye Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1045 N Grand Ave Ste E, Pullman, WA 99163 Phone: 509-334-3610 Fax: 509-334-1436 |